In order to accelerate the task force progress and solving still persistent problems and disagreements a short-dated conference was held at the Institute for Occupational and Maritime Medicine in Hamburg, Germany February 26th 2010 focusing on general aspects of the guidelines, e.g. form of publication and how to condense the extensive manuscript. Further, the final formulation of the evidence statements and recommendations was finished. It was agreed to perform an update of the literature search to make sure that new publications are considered. Due to the relatively autonomous work of the different working groups a substantial lack of uniformity between the different chapters was recognizable and all groups were asked to adapt the structure of their chapters and the evidence tables. It was decided that a small editing group should finalize the draft manuscript after the final meeting at the ERS congress in Barcelona 2010.
The essential topic of this meeting was the presentation and the discussion of the final drafts from each working group. In cases of disagreements consensus was found. All manuscripts were accepted by all members of the task force. Another main aspect was the publication strategy of the guidelines.
According to the proceedings of the ERS we initially intended to publish the guidelines in ERJ together with an editorial and online supplements. After communicating this aspects with ERS officials especially the ERS guideline coordinator and taking into consideration the extensiveness of the existing manuscript, it was decided to publish one summary chapter in the ERJ and separate adjacent chapter for each key question in the ERR together with one chapter presenting the guidelines in a broader perspective.
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In addition two papers that are based on the task force results going beyond the aims of the guideline are in preparation, i.e. exposure reduction vs. exposure avoidance by Olivier Vandenplas and one publication one diagnostics in work-related asthma.
The major activity since the last meeting was the editing of the exiting chapters in order to have a uniform style (layout, references etc.) for all publications and to fulfil the ERJ / ERR requirements.
Even though every key question should become a separate publication, relevant shortenings became necessary for every manuscript. To guarantee the uniform style and in order to avoid incompatibilities, an editorial team was formed. This team was meant to be responsible for the final editing of all chapters.
Meanwhile all guideline chapters are published or in print. We have initiated a symposium at the ERS congress in Amsterdam in order to present the guidelines to a broad public and to begin a lively discussion about the management of occupational asthma between all medical and paramedical participants in this field.
The formal guideline project was reached after final publication of the submitted manuscripts and after the Amsterdam meeting. To make sure that the guideline will keep its initial high level of quality, regular updates and ongoing evaluation of the field of occupations asthma are important.
A further remaining task is to enhance the translation of the guidelines content from theory into daily practical work. Therefore, we have to promote the implementation of the guidelines recommendations into national regulations / legislations. To make sure these attempted goals can be reached, a further promotion of the guidelines at national and international congresses / conferences is essential. A joined strategy by the whole task force and a close cooperation beyond the first publication has to be established and additional publications on separate aspects in the light of local / national conditions could became necessary. and/or severity of asthma attacks) due to causes and conditions attributable to a particular occupational environment and not to stimuli encountered outside the workplace. The worker has a concurrent history of asthma that was not induced by an exposure in the workplace. Aggravation is typically due to an occupational irritant (e.g. non-sensitizing fumes) [3] .
PUBLICATIONS
There are also workers with pre-existing asthma who after a latent interval have a worsening of their pre-existing non-occupational asthma with regular daily exposures to agents which can cause IgEmediated allergies in others. These workers are included in the group of occupational asthma or in that of work aggravated asthma, depending on national regulations and related case definitions.
Some occupational exposures which are potential causes of occupational asthma, particularly high concentrations of welding fumes, isocyanates, potroom and a range of other occupational noxae (e.g. aluminium, cadmium, metals, ammonia, environmental tobacco smoke, wood dust, cotton, endotoxin) may also cause COPD, without any acute symptoms to suggest asthma [4] [5] [6] [7] [8] [9] [10] [11] .
Furthermore, symptoms in asthmatics that do not improve over weekends or during holidays may indicate a progressive course and may coincide with symptoms typical for COPD patients. This observation also applies to occupational asthma [6, 12] ; so, there is evidence for a group with 7 C:\Users\Franz\Downloads\finalreport_220612.doc EndNote: occupational asthma copy copy copy copy changing diagnoses as well as with some overlap between occupational asthma and occupational COPD [5, 6, [13] [14] [15] [16] .
Recently, Blanc and Torén [17] reviewing the literature estimated the population attributable risk of the latter to be 15 % which indicates that the occupational causes of these disorders are mostly overlooked in routine diagnostics. Misdiagnoses result mainly due to the lack of specific diagnostic tests, the absence of attacks of shortness of breath and the frequent concomitant smoking habits as a confounder. Salvi and Barnes [18] [22] .
Several other conditions with some overlap represent risk factors for occupational asthma including eosinophilic bronchitis, asthma-like symptoms and work-related rhinitis [2] .
Since the before mentioned overlapping occupational disorders have not been subjected to detailed scientific investigations these guidelines will focus on WRA .
Adverse consequences for the affected workers
Follow-up studies of workers with occupational asthma have consistently documented that the condition is associated with a high rate of prolonged work disruption or even permanent unemployment (14-69%) and loss of income (44-74%) [23] [24] [25] . The financial consequences of occupational asthma are more pronounced in workers who avoid further exposure to the causal agent. Notably, the lowest rates of unemployment (14-25%) have been reported in countries (i.e.
Finland and Canada) where a high proportion of workers with occupational asthma actually do benefit from effective job retraining programs. A lower level of education and being older are also associated with a worse socioeconomic outcome. Retraining possibilities for a new occupation are often ineffectual, especially in older workers [23, 24] . The severity of asthma does not appear to be an important determinant for the socioeconomic outcome in subjects with occupational asthma, with the exception of one cohort of Finnish workers with isocyanate-induced occupational asthma [26] . The disease-related loss of income is only offset by the financial compensation awarded in a minority of affected workers. Recent data indicate that subjects with work-related asthma show higher healthcare resource utilisation than asthmatic subjects without work-related symptoms [27] .
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There is evidence that occupational asthma is associated with an adverse impact on healthcare resource utilisation [27] , quality of life [26, 28, 29] and mental well-being [29, 30] .
There are only scarce data available for workers suffering from work-aggravated asthma [86] and none for those suffering from occupational COPD. It can be assumed that their outcome does not differ substantially from that already described for the occupational asthma sufferers.
Objectives and audiences of these guidelines
WRA is a preventable diseases. The same is true for occupational COPD. Relevant legal definitions, regulations as well as measures on prevention, diagnosis, compensation, and rehabilitation differ considerably between countries, some having lower standards than others.
The objective of this task force is the development of European guidelines for the management of work-related asthma in order to standardize and optimize the management of patients with WRA.
Addressing also legislative authorities in the sector of public health, it is hoped this work could help to assimilate the different European compensation systems.
A further task was to propose evidence-based recommendations in order to extend and if necessary modify the available national guidelines regarding these topics.
Another objective is to compile useful information, such as legal framework for the prevention of occupational asthma in individual countries, in order to describe the basis for improving primary and secondary prevention. It is intended to focus on this issue in a future publication, also preparing a set of cases with the aim to compare management and compensation systems for WRA in different countries, and providing content for leaflets to help guide different audiences.These guidelines cover both primary and secondary prevention. Tertiary prevention, rehabilitation and compensation issues are addressed but not in detail.
These evidence-based guidelines take into consideration already existing guidelines and reports for the prevention of occupational asthma [2] including the British Occupational Health Research Foundation (BOHRF) [31] , American College of Chest Physicians (ACCP) [3] , Agency for Healthcare
Research and Quality (AHRQ) [32] (Table 1 ).
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An initial step was to summarize the available knowledge with evidence-based findings. This comprised recommendations on the frequency and causes of occupational asthma in order to show the urgent necessity for intensified prevention efforts. Evidence regarding prevention, diagnostic tools and management was critically reviewed.
Our main focus was on the articles retrieved from extensive systematic searches of the literature in order to answer the five key questions and their ancillary questions. These guidelines have two primary audiences: 1) workers in all industrial and occupational sectors; and 2) health care providers and practitioners, such as occupational physicians and primary care physicians involved in diagnosis, treatment, and/or education. In addition, political parties, policy makers, industrial physicians, workers' and employers' representatives with responsibility for the safety and health of workers may benefit from the guideline. The knowledge summarized in this document might help them to improvement company policies and legal regulations related to WRA. However, the guidelines do not focus on management tools for governmental authorities.
For more detailed information see the summary chapter "Overview of the Guidelines Management (Table 3) .
Specific questions arising at subsequent Task Force meetings were included as ancillary questions.
Literature review
Appropriate terms were used to search Medline via PubMed (www.ncbi.nlm.nih.gov/pubmed; see useful by the individual working group, and assessed according to the method already described. For these additional searches, the same selection criteria were applied, as described above (see Table   sO2 for the deepening search results). Disagreements were resolved by discussion and/or consulting the whole Task Force. The evidence relevant to the two working groups on prognostic factors, surveillance and primary prevention often consisted of observational study designs. The studies were assessed for potential biases (selection, confounding, information bias), considering the sources of bias and bias minimisation strategies in either the design or analysis phase, specific to each study design. For primary prevention studies, where measurement of exposure to occupational agents plays a crucial role, the exposure assessment component was specifically considered, using criteria described in a World Health Organization working document [35] for exposure assessment studies in epidemiological surveys, and applied by LENTERS et al. [36] in a meta-analysis for asbestos.
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Synthesis
The heterogeneity of the studies in the following areas prevented the use of sophisticated methods of meta-analysis for the majority of questions. This refers to study designs (cross-sectional, casecontrol, longitudinal), measurement methods for disease end-points or intermediate end-points such as sensitisation, and epidemiological end-points; (repeated measurements in longitidudinal studies versus incidence data), measurement methods for the determinants considered, and the statistical methods applied. Narrative summaries were written in these cases. The available evidence often consisted of a crosssectional survey with relatively low SIGN scores. The combined power (study size or number of patients) answering a specific question was considered to give an impression of the discriminatory power of the study by providing an intuitive estimate of precision. For key question 3, study design and measurement methods of the included intervention studies were comparable and a meta-analysis could be conducted. The pooled odds ratio (based on available individual studies) was calculated for each outcome after reduction or cessation of exposure using a random-effect model because heterogeneity between studies was observed. Full details about the methodology used are given elsewhere [37] . Table sO3 .
Strength of evidence and grading of recommendation
The strength of the evidence for each question was graded according to the three-star system of the Royal College of General Practitioners (RCGP), which includes the quality and the quantity of the evidence [38] . 
Results
For further details see individual publications listed above. 
DISCUSSION
The Global Initiative for Asthma (GINA) has revised its guidelines and changed its focus from asthma severity to asthma control, with an emphasis on carefully titrating drug doses, according to the level of control [41, 42] . This new understanding is also relevant for management of work-related asthma.
However, in terms of work-related asthma, the benefits from avoiding exposure far exceed those of drug treatment.
In clinical decision-making for work-related asthma, physicians must be able to i) identify whether a patient is adequately controlled ii) understand how increments of control can be achieved by adjusting exposure levels and/or the regimen iii) evaluate the resulting improvements or lack thereof.
A recent paper evaluated and compared existing instruments for measuring asthma control [42, 43] . Evaluating the outcome of work-related asthma is not only based on clinical aspects but includes physiological as well as social variables. The relevant literature was recently summarised in systematic reviews [44] [45] [46] . RACHIOTIS et al. [44] summarised as follows: ''one third of patients with occupational asthma will recover fully from their disease following avoidance of exposure to the initiating agent. This proportion seems not to be related to the duration of avoidance. In most cases, non-specific bronchial responsiveness detected at diagnosis persists. There was evidence that symptomatic outcomes worsened with increasing age and with duration of symptomatic exposure, although the latter was not significant.''
For results of our literature search on the clinical outcome of work-related asthma, see online supplementary text sO5.
In conclusion, we suggest to orientate on existing recommendations from GINA when the effect of interventions on clinical and physiological indices of work-related asthma is assessed and tried to be improved as well as to control the consequences on employment and income. Work-related symptoms, lung function deterioration and sensitisation are major parameters for decision-making in work-related asthma management. The combination of a questionnaire, with results of SPT and/or IgE tests, increases the predictive value significantly [47] . Screening as well as surveillance results and NSBHR were found to be informative prognostic parameters in high-risk workers. Since the level of exposure to allergenic or irritative airborne agents is the dominant risk factor for work-related asthma, exposure avoidance or at least reduction as primary preventive measures are the most effective approaches. This is obviously also true for occupational COPD [17, 19, 48] . There is less evidence for the effectiveness of secondary prevention, in which sensitisation or early symptoms are Furthermore, there is a need for patient health education, in an effort to improve the individual's ability to cope with unplanned harmful exposures, exacerbation episodes, avoidance of risk factors and smoking cessation. We also recommend providing detailed information to employees, employers and medical personnel, which should lead to increased awareness and earlier detection of workrelated asthma and occupational COPD. We recommend notification to accessible registers and systematic surveys that may detect increased occurrence of asthma and COPD in populations. Since many epidemiological studies are hypothesis-generating, this may lead to more focused investigations, which in turn may form a basis for prevention.
Future research aspects
Given the limited evidence available, additional research is required to demonstrate the effectiveness of primary preventive measures on: allergen exposure; and the occurrence of allergy and asthma for most allergens. In general, studies that make use of strong analytical designs, such as Given earlier information, it is important to evaluate the independent and additional predictive value of diagnostic tests. Prediction research provides an appropriate solution by using a multivariate approach in design and analysis that accounts for mutual dependence between different test results.
The information from these tests can then be translated into a predicted probability of the chosen outcome. Prediction models applied in occupational health practice may therefore enable an occupational physician to deal with uncertainties in considering workers at risk of having occupational diseases.
Research is needed to assess the prognostic value of sex, type of asthmatic response to specific agents, and other determinants at diagnosis. Furthermore, most research on risk factors for a bad outcome is performed on a limited number of exposures, i.e. isocyanates and western red cedar. So it is crucial to include other exposures in the research field as well.
Although its role in disease management is not disputed, there are important questions that are still awaiting answers: when and how to set up medical surveillance; and which tests, test frequency and outcome parameters should be used in different occupational groups. As direct evidence for the benefit of medical surveillance is scarcely available, there is a need for prospective studies using clearly defined instruments and outcomes.
Large-scale, standardised studies on the prognosis of occupational asthma and its determinants after environmental interventions are required in order to provide evidence-based recommendations to affected workers, employers and policy makers. Prospective studies of the prognosis of occupational asthma should use the outcomes that have been validated for asthma in general.
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